Nondiabetic kidney diseases in type 2 diabetic patients

Abstract Background The aim of this study was to evaluate the clinical characteristics of nondiabetic nephropathy in type 2 diabetes mellitus patients and to find a clinical significance of renal biopsy and immunosuppressive treatment in such a patient. Methods Renal biopsy results, clinical paramet...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Kidney research and clinical practice 2013, 32(3), , pp.115-120
Hauptverfasser: Jin Kim, Ye, Hyung Kim, Yoo, Dae Kim, Ki, Ryun Moon, Kang, Ho Park, Jae, Mi Park, Bo, Ryu, Hyewon, Eun Choi, Dae, Ryang Na, Ki, Sun Suh, Kwang, Wook Lee, Kang, Tai Shin, Young
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract Background The aim of this study was to evaluate the clinical characteristics of nondiabetic nephropathy in type 2 diabetes mellitus patients and to find a clinical significance of renal biopsy and immunosuppressive treatment in such a patient. Methods Renal biopsy results, clinical parameters, and renal outcomes were analyzed in 75 diabetic patients who underwent kidney biopsy at Chungnam National University Hospital from January 1994 to December 2010. Results The three most common reasons for renal biopsy were nephrotic range proteinuria (44%), proteinuria without diabetic retinopathy (20%), and unexplained decline in renal function (20.0%). Ten patients (13.3%) had only diabetic nephropathy (Group I); 11 patients (14.7%) had diabetic nephropathy with superimposed nondiabetic nephropathy (Group II); and 54 patients (72%) had only nondiabetic nephropathy (Group III). Membranous nephropathy (23.1%), IgA nephropathy (21.5%), and acute tubulointerstitial nephritis (15.4%) were the three most common nondiabetic nephropathies. Group III had shorter duration of diabetes and lesser diabetic retinopathy than Groups I and II ( P =0.008). Group II had the lowest baseline estimated glomerular filtration rate ( P =0.002), with the greatest proportion of renal deterioration during follow-up (median 38.0 months, P
ISSN:2211-9132
2211-9140
DOI:10.1016/j.krcp.2013.07.002